Faculty of Health Sciences, McMaster University, 1280 Main Street West, Room HSC 2J20A, Hamilton, ON L8S 4K1, Canada.
BMC Cardiovasc Disord. 2014 Feb 1;14:14. doi: 10.1186/1471-2261-14-14.
Chronic stable angina (CSA) has a major negative impact on health-related quality of life (HRQL) including poor general health status, psychological distress, and inability to self-manage.
We used meta-analysis to assess the effectiveness of self-management interventions for improving stable angina symptoms, HRQL and psychological well-being. Nine trials, involving 1,282 participants in total, were included. We used standard inverse-variance random-effects meta-analysis to combine the trials. Heterogeneity between trials was evaluated using chi-square tests for the tau-squared statistic and quantified using the I2 statistic.
There was significant improvement in the frequency of angina symptoms (Seattle Angina Questionnaire [SAQ], symptom diary) across trials, standardized mean difference (SMD): 0.30 (95% Confidence interval [CI] 0.14, 0.47), as well as reduction in the use of sublingual (SL) nitrates, SMD: -0.49 (95% CI -0.77, -0.20). Significant improvements for physical limitation (SAQ), SMD: 0.38 (95% CI 0.20, 0.55) and depression scores (Hospital Anxiety and Depression Scale), SMD: -1.38 (95% CI -2.46, -0.30) were also found. The impact of SM on anxiety was uncertain due to statistical heterogeneity across trials for this outcome, I2 = 98%. SM did not improve other HRQL dimensions including angina stability, disease perception, and treatment satisfaction.
SM interventions significantly improve angina frequency and physical limitation; they also decrease the use of SL nitrates and improve depression in some cases. Further work is needed to make definitive conclusions about the impact of SM on cardiac-specific anxiety.
慢性稳定型心绞痛(CSA)对健康相关生活质量(HRQL)有重大负面影响,包括一般健康状况不佳、心理困扰和无法自我管理。
我们使用荟萃分析评估自我管理干预对改善稳定型心绞痛症状、HRQL 和心理幸福感的有效性。共纳入 9 项试验,涉及 1282 名参与者。我们使用标准逆方差随机效应荟萃分析对试验进行组合。使用 tau 平方统计量的卡方检验和 I2 统计量来评估试验之间的异质性。
各试验中心绞痛症状(西雅图心绞痛问卷[SAQ],症状日记)的发生频率均有显著改善,标准化均数差(SMD):0.30(95%置信区间[CI] 0.14,0.47),舌下(SL)硝酸酯的使用也减少了,SMD:-0.49(95% CI -0.77,-0.20)。SAQ 中的身体限制也有显著改善,SMD:0.38(95% CI 0.20,0.55),抑郁评分(医院焦虑和抑郁量表),SMD:-1.38(95% CI -2.46,-0.30)。由于试验之间存在统计学异质性,SM 对焦虑的影响不确定,I2 = 98%。SM 并没有改善其他 HRQL 维度,包括心绞痛稳定性、疾病认知和治疗满意度。
SM 干预显著改善心绞痛发作频率和身体限制;它们还减少了 SL 硝酸酯的使用,并在某些情况下改善了抑郁。需要进一步的工作来确定 SM 对心脏特定焦虑的影响。